Evaluation Of The Effect Of Morphological Structure On Dilatational

Status Completed

Clinical Trial Summary

In recent years, percutaneous dilatational tracheostomy has become a frequently performed procedure in intensive care units. However, tracheostomy procedure has risks of complications of varying severity, such as bleeding, subcutaneous emphysema, posterior tracheal wall damage, tracheal stenosis, infection, and fistula in the early and late periods. It is important to determine the anatomical position for tracheal puncture in reducing the risk of complications. It is not always possible to determine the optimal anatomical position for tracheal puncture in patients in the intensive care unit due to reasons such as obesity patient positioning difficulties and tracheal deviation. In this stuy, we have purpose to evaluate the effect of the morphological structure of patients on the dilatational tracheostomy interference location and complications in the percutaneous dilatational tracheostomy procedure (using anatomical landmarks) performed with the forceps dilatation technique, using fiberoptic bronchoscopy and ultrasonography.

Clinical Trial Description

A prospective observational study will be conducted in the Akdeniz University Hospital at the department of Anesthesiology and Intensive Care. Tracheostomy incision site will be determined by using anatomical landmark in all patients. Before the procedure, detailed anatomical measurements showing the morphological structure of the patient (neck thickness, thyromental distance, thyroid cartilage measurement, cricoid cartilage measurement, jugulomental distance, distance between clavicle and cricoid cartilage) will be recorded. In addition, measurements will be made and recorded by ultrasonography. In all patients, the percutaneous dilatational tracheostomy procedure will be performed via fiberoptic bronchoscopy and the tracheal puncture level will be confirmed. Tracheostomy related complications will also be recorded. ;

Study Design

Related Conditions & MeSH terms

Tracheostomy Complication

Clinical Trial Details

NCT number	NCT05845775
Study type	Observational
Source	Akdeniz University
Contact
Status	Completed
Phase
Start date	April 30, 2023
Completion date	February 2, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05084976` - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Active, not recruiting	`NCT04308109` - Simulation Training in the Pediatric Tracheostomy and Home Ventilator Population	N/A
Recruiting	`NCT02495558` - Cough Assessment in Patients With Severe Acquired Brain Injury	N/A
Completed	`NCT04637932` - Percutaneous Dilatation Tracheostomy, Broncoscopy, Pro-seal Laryngeal Mask	N/A
Completed	`NCT05499273` - Pediatric Neck Rescue Access Comparison	N/A
Recruiting	`NCT04565405` - Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas	N/A
Recruiting	`NCT05395728` - Deflating the Tracheostomy Tube Cuff and Time for Decannulation	N/A
Withdrawn	`NCT02074254` - Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors
Not yet recruiting	`NCT02096640` - Postoperative Inflammation and Recovery After Tracheostomy	N/A
Completed	`NCT05045885` - Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO
Completed	`NCT04744909` - Navigation System for Percutaneous Tracheotomy	N/A
Completed	`NCT04412356` - Timing of Tracheotomy in Covid-19 Patients	N/A
Recruiting	`NCT06018220` - Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
Not yet recruiting	`NCT05834972` - Ultrasound-guided Versus Landmark-guided Percutaneous Dilational Tracheostomy in Pediatric Patients
Not yet recruiting	`NCT05418517` - Hospital Acquired Pneumonia in Temporary Tracheostomy
Withdrawn	`NCT04685902` - Assessing Upper Airway Patency in Tracheostomy Patients During One Way Speaking Valve Trial
Completed	`NCT04987398` - Ventilation Weaning Strategies and Correlation to Outcomes in Tracheostomized Patients in the Lausanne ICU
Completed	`NCT03431389` - "Outcomes of Tracheostomy Done for Patients Admitted in Anesthesia Intensive Care Units of Assiut University Hospital"	Phase 2/Phase 3
Withdrawn	`NCT03325725` - Intra-laryngeal Implant for Treatment of Chronic Aspirations	N/A
Completed	`NCT05595707` - Expert-Guided Early Tracheostomy Pathway	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation Of The Effect Of Morphological Structure On Dilatational Tracheostomy Interference Location And Complications

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms